540 related articles for article (PubMed ID: 18316487)
21. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.
Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Tsutsui H; Kaibuchi K; Takeshita A
Circulation; 2004 May; 109(18):2234-9. PubMed ID: 15096457
[TBL] [Abstract][Full Text] [Related]
22. Injectable hydrogels derived from phosphorylated alginic acid calcium complexes.
Kim HS; Song M; Lee EJ; Shin US
Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():139-47. PubMed ID: 25842118
[TBL] [Abstract][Full Text] [Related]
23. Tunable injectable alginate-based hydrogel for cell therapy in Type 1 Diabetes Mellitus.
Espona-Noguera A; Ciriza J; Cañibano-Hernández A; Fernandez L; Ochoa I; Saenz Del Burgo L; Pedraz JL
Int J Biol Macromol; 2018 Feb; 107(Pt A):1261-1269. PubMed ID: 28962846
[TBL] [Abstract][Full Text] [Related]
24. Alginate hydrogel as a potential alternative to hyaluronic acid as submucosal injection material.
Kang KJ; Min BH; Lee JH; Kim ER; Sung CO; Cho JY; Seo SW; Kim JJ
Dig Dis Sci; 2013 Jun; 58(6):1491-6. PubMed ID: 23344967
[TBL] [Abstract][Full Text] [Related]
25. Injectable Fullerenol/Alginate Hydrogel for Suppression of Oxidative Stress Damage in Brown Adipose-Derived Stem Cells and Cardiac Repair.
Hao T; Li J; Yao F; Dong D; Wang Y; Yang B; Wang C
ACS Nano; 2017 Jun; 11(6):5474-5488. PubMed ID: 28590722
[TBL] [Abstract][Full Text] [Related]
26. The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction.
Kadner K; Dobner S; Franz T; Bezuidenhout D; Sirry MS; Zilla P; Davies NH
Biomaterials; 2012 Mar; 33(7):2060-6. PubMed ID: 22153866
[TBL] [Abstract][Full Text] [Related]
27. Increased Survival and Function of Mesenchymal Stem Cell Spheroids Entrapped in Instructive Alginate Hydrogels.
Ho SS; Murphy KC; Binder BY; Vissers CB; Leach JK
Stem Cells Transl Med; 2016 Jun; 5(6):773-81. PubMed ID: 27057004
[TBL] [Abstract][Full Text] [Related]
28. Static cardiomyoplasty with synthetic elastic net suppresses ventricular dilatation and dysfunction after myocardial infarction in the rat: a chronic study.
Kato N; Kawaguchi AT; Kishida A; Yamaoka T
Artif Organs; 2013 Jul; 37(7):593-9. PubMed ID: 23461677
[TBL] [Abstract][Full Text] [Related]
29. Self-healing polysaccharide-based hydrogels as injectable carriers for neural stem cells.
Wei Z; Zhao J; Chen YM; Zhang P; Zhang Q
Sci Rep; 2016 Nov; 6():37841. PubMed ID: 27897217
[TBL] [Abstract][Full Text] [Related]
30. Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling.
Wang T; Wu DQ; Jiang XJ; Zhang XZ; Li XY; Zhang JF; Zheng ZB; Zhuo R; Jiang H; Huang C
Eur J Heart Fail; 2009 Jan; 11(1):14-9. PubMed ID: 19147452
[TBL] [Abstract][Full Text] [Related]
31. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
[TBL] [Abstract][Full Text] [Related]
32. Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook: From ocean algae to patient bedside.
Ruvinov E; Cohen S
Adv Drug Deliv Rev; 2016 Jan; 96():54-76. PubMed ID: 25962984
[TBL] [Abstract][Full Text] [Related]
33. Short-term ventricular restraint attenuates post-infarction remodeling in rats.
Vilaeti AD; Dimos K; Lampri ES; Mantzouratou P; Tsitou N; Mourouzis I; Oikonomidis DL; Papalois A; Pantos C; Malamou-Mitsi V; Agathopoulos S; Kolettis TM
Int J Cardiol; 2013 May; 165(2):278-84. PubMed ID: 21917336
[TBL] [Abstract][Full Text] [Related]
34. Preliminary investigation of calcium alginate gel as a biocompatible material for endovascular aneurysm embolization in vivo.
Becker TA; Preul MC; Bichard WD; Kipke DR; McDougall CG
Neurosurgery; 2007 Jun; 60(6):1119-27; discussion 1127-8. PubMed ID: 17538387
[TBL] [Abstract][Full Text] [Related]
35. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds.
Balakrishnan B; Jayakrishnan A
Biomaterials; 2005 Jun; 26(18):3941-51. PubMed ID: 15626441
[TBL] [Abstract][Full Text] [Related]
36. Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.
Li J; Jubair S; Janicki JS
Hypertension; 2015 Feb; 65(2):328-34. PubMed ID: 25403608
[TBL] [Abstract][Full Text] [Related]
37. Fully defined in situ cross-linkable alginate and hyaluronic acid hydrogels for myocardial tissue engineering.
Dahlmann J; Krause A; Möller L; Kensah G; Möwes M; Diekmann A; Martin U; Kirschning A; Gruh I; Dräger G
Biomaterials; 2013 Jan; 34(4):940-51. PubMed ID: 23141898
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
Yarbrough WM; Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Escobar GP; Joffs C; Lucas DG; Crawford FA; Spinale FG
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):602-10. PubMed ID: 12658202
[TBL] [Abstract][Full Text] [Related]
39. Physical properties of poly(N-isopropylacrylamide) hydrogel promote its effects on cardiac protection after myocardial infarction.
Ren S; Jiang X; Li Z; Wen Y; Chen D; Li X; Zhang X; Zhuo R; Chu H
J Int Med Res; 2012; 40(6):2167-82. PubMed ID: 23321174
[TBL] [Abstract][Full Text] [Related]
40. An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failure.
Curley CJ; Dolan EB; Otten M; Hinderer S; Duffy GP; Murphy BP
Drug Deliv Transl Res; 2019 Feb; 9(1):1-13. PubMed ID: 30511249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
